Trial Profile
A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2012
Price :
$35
*
At a glance
- Drugs Dextromethorphan/quinidine (Primary) ; Memantine (Primary)
- Indications Alzheimer's disease; Emotional lability; Pain
- Focus Pharmacokinetics
- Sponsors Avanir Pharmaceuticals
- 06 Sep 2012 New trial record